LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. The company is headquartered in Princeton, New Jersey and currently employs 163 full-time employees. The company went IPO on 2021-10-28. The firm is also pursuing the sale of its remaining pipeline assets.
LianBio hisse başına yıllık % {var1} temettüye sahiptir ve % {var2} oranında bir getiri sunmaktadır. Temettü diğer/bilinmiyor ödenmektedir ve son temettü hariç tarihi Jul 15, 2025 tarihindedir.